Annals of Translational Medicine,
Journal Year:
2018,
Volume and Issue:
6(10), P. 176 - 176
Published: May 1, 2018
Abstract:
Alzheimer’s
disease
(AD)
is
a
chronic
and
progressive
neurodegenerative
of
central
nervous
system
(CNS).
Nowadays,
increasing
evidence
suggests
that
immune
plays
significant
role
in
the
mechanisms
AD’s
onset
progression.
Microglia,
main
participator
CNS,
always
regarded
as
protector
our
brain
healthy
state
also
has
beneficial
maintaining
homeostasis
CNS
microenvironment.
However,
sustained
stimulation
can
push
microglia
into
termed
priming.
Primed
induce
production
amyloid
β
(Aβ),
tau
pathology,
neuroinflammation
reduce
release
neurotrophic
factors,
resulting
loss
normal
neurons
quantity
function
immense
relationship
with
AD.
The
therapeutic
strategies
mainly
aimed
at
modulating
microenvironment
microglial
activity
to
delay
progression
alleviate
pathogenesis
Overall,
this
review,
we
highlight
mechanism
priming,
discuss
profound
between
priming
Besides,
pay
attention
targeting
Frontiers in Pharmacology,
Journal Year:
2018,
Volume and Issue:
9
Published: Oct. 16, 2018
Aging
is
the
progressive
loss
of
organ
and
tissue
function
over
time.
Growing
older
positively
linked
to
cognitive
biological
degeneration
such
as
physical
frailty,
psychological
impairment,
decline.
Oxidative
stress
considered
an
imbalance
between
pro-
antioxidant
species,
which
results
in
molecular
cellular
damage.
plays
a
crucial
role
development
age-related
diseases.
Emerging
research
evidence
has
suggested
that
can
control
autoxidation
by
interrupting
propagation
free
radicals
or
inhibiting
formation
subsequently
reduce
oxidative
stress,
improve
immune
function,
increase
healthy
longevity.
Indeed,
oxidation
damage
highly
dependent
on
inherited
acquired
defects
enzymes
involved
redox-mediated
signaling
pathways.
Therefore,
molecules
with
activity
promote
aging
counteract
worth
discuss
further.
Of
particular
interest
this
article,
we
highlighted
mechanisms
antioxidants
prevention
Taken
together,
better
understanding
redox
modulation
inflammation
would
provide
useful
approach
for
potential
interventions,
promoting
Journal of Neurology Neurosurgery & Psychiatry,
Journal Year:
2017,
Volume and Issue:
88(10), P. 876 - 882
Published: Aug. 9, 2017
Objectives
Increasing
evidence
suggests
that
inflammation
is
involved
in
Alzheimer’s
disease
(AD)
pathology.
This
study
quantitatively
summarised
the
data
on
peripheral
inflammatory
markers
patients
with
AD
compared
healthy
controls
(HC).
Methods
Original
reports
containing
measurements
of
and
HC
were
included
for
meta-analysis.
Standardised
mean
differences
calculated
using
a
random
effects
model.
Meta-regression
exploration
heterogeneity
was
performed
publication
year,
age,
gender,
Mini-Mental
State
Examination
(MMSE)
scores,
plasma
versus
serum
immunoassay
type.
These
findings
suggest
accompanied
by
response
may
be
useful
biological
marker
correlate
severity
cognitive
impairment.
Further
are
needed
determine
clinical
utility
these
markers.
Frontiers in Aging Neuroscience,
Journal Year:
2018,
Volume and Issue:
10
Published: Jan. 30, 2018
Alzheimer's
disease
(AD)
is
the
most
common
cause
of
progressive
dementia
in
elderly.
It
characterized
by
a
and
irreversible
loss
cognitive
abilities
formation
senile
plaques,
composed
mainly
amyloid
β
(Aβ),
neurofibrillary
tangles
(NFTs),
tau
protein,
hippocampus
cortex
afflicted
humans.
In
brains
AD
patients
metabolism
Aβ
dysregulated,
which
leads
to
accumulation
aggregation
Aβ.
Metabolism
proteins
crucially
influenced
autophagy.
Autophagy
lysosome-dependent,
homeostatic
process,
organelles
are
degraded
recycled
into
energy.
Thus,
dysfunction
autophagy
suggested
lead
accretion
noxious
brain.
present
review,
we
describe
process
its
importance
AD.
Additionally,
discuss
mechanisms
genes
linking
AD,
i.e.,
mTOR
pathway,
neuroinflammation,
endocannabinoid
system,
ATG7,
BCL2,
BECN1,
CDK5,
CLU,
CTSD,
FOXO1,
GFAP,
ITPR1,
MAPT,
PSEN1,
SNCA,
UBQLN1,
UCHL1.
We
also
pharmacological
agents
acting
via
modulation
that
may
show
promise
therapy.
This
review
updates
our
knowledge
on
proposing
novel
therapeutic
targets
for
treatment
International Journal of Molecular Medicine,
Journal Year:
2018,
Volume and Issue:
unknown
Published: Jan. 19, 2018
Oxidative
stress
is
increasingly
recognized
as
a
central
event
contributing
to
the
degeneration
of
dopaminergic
neurons
in
pathogenesis
Parkinson's
disease
(PD).
Although
reactive
oxygen
species
(ROS)
production
implicated
causative
factor
PD,
cellular
and
molecular
mechanisms
linking
oxidative
with
neuron
death
are
complex
not
well
characterized.
The
primary
insults
cause
greatest
ROS,
which
contributes
damage
by
attacking
all
macromolecules,
including
lipids,
proteins
nucleic
acids,
leading
defects
their
physiological
function.
Consequently,
these
macromolecules
result
mitochondrial
dysfunction
neuroinflammation,
subsequently
enhance
ROS
ultimately
neuronal
damage.
interaction
between
various
forms
positive
feedback
loop
that
drives
progressive
loss
stress‑mediated
appears
serve
role
neurodegenerative
process.
Thus,
understanding
may
provide
promising
therapeutic
approach
PD
treatment.
Journal of Alzheimer s Disease,
Journal Year:
2015,
Volume and Issue:
48(2), P. 319 - 353
Published: Sept. 9, 2015
This
review
focuses
on
research
in
epidemiology,
neuropathology,
molecular
biology,
and
genetics
regarding
the
hypothesis
that
pathogens
interact
with
susceptibility
genes
are
causative
sporadic
Alzheimer's
disease
(AD).Sporadic
AD
is
a
complex
multifactorial
neurodegenerative
evidence
indicating
coexisting
multi-pathogen
inflammatory
etiologies.There
significant
associations
between
various
pathogens,
including
Herpes
simplex
virus
type
1
(HSV-1),
Cytomegalovirus,
other
Herpesviridae,
Chlamydophila
pneumoniae,
spirochetes,
Helicobacter
pylori,
periodontal
pathogens.These
able
to
evade
destruction
by
host
immune
system,
leading
persistent
infection.Bacterial
viral
DNA
RNA
bacterial
ligands
increase
expression
of
pro-inflammatory
molecules
activate
innate
adaptive
systems.Evidence
demonstrates
directly
indirectly
induce
pathology,
amyloid-
(A)
accumulation,
phosphorylation
tau
protein,
neuronal
injury,
apoptosis.Chronic
brain
infection
HSV-1,
spirochetes
results
processes
cause
vicious
cycle
uncontrolled
neuroinflammation
neurodegeneration.Infections
such
as
production
systemic
cytokines
may
cross
blood-brain
barrier
promote
neurodegeneration.Pathogen-induced
inflammation
central
nervous
system
accumulation
A
damages
barrier,
which
contributes
pathophysiology
AD.Apolipoprotein
E4
(ApoE4)
enhances
infiltration
HSV-1
pneumoniae.ApoE4
also
associated
an
increased
response
system.Potential
antimicrobial
treatments
for
discussed,
rationale
antiviral
antibiotic
clinical
trials.
Journal of Alzheimer s Disease,
Journal Year:
2017,
Volume and Issue:
56(4), P. 1469 - 1484
Published: Feb. 1, 2017
Recent
work
has
suggested
that
exercise
may
be
beneficial
in
preventing
or
ameliorating
symptoms
of
several
neurological
disorders,
although
the
mechanism
is
not
entirely
understood.
The
current
study
was
designed
to
examine
potential
effect
treadmill
upon
cognitive
function
a
streptozotocin
(STZ)-induced
rat
model
Alzheimer’s
disease
(AD).
Animals
underwent
(30
min/day,
5
days/week)
for
4
weeks
after
bilateral
STZ
intracerebroventricular
injection
(2.4
mg/kg).
We
demonstrated
significantly
attenuated
STZ-induced
neurodegeneration
hippocampal
CA1
region
and
strongly
preserved
hippocampal-dependent
functioning.
Further
mechanistic
investigation
displayed
marked
suppression
amyloid-β
accumulation
tau
phosphorylation.
Intriguingly,
remarkably
inhibited
reactive
gliosis
following
insult
effectively
shifted
activated
microglia
from
pro-inflammatory
M1
an
anti-inflammatory
M2
phenotype,
which
correlated
with
reduced
expression
mediators
corresponding
enhancement
cytokine
hippocampus.
Furthermore,
caused
robust
oxidative
damage
as
evidenced
by
peroxynitrite
production,
lipid
peroxidation,
oxidized
DNA
damage.
Finally,
mitochondrial
dysfunction
manifested
dramatically
elevated
intra-mitochondrial
cytochrome
c
oxidase
activity
ATP
synthesis,
markedly
neuronal
apoptosis
These
findings
demonstrate
multifactorial
attenuate
many
pathological
processes
play
key
role
AD,
provide
further
support
therapeutic
option
AD
treatment.
Cell Death and Disease,
Journal Year:
2022,
Volume and Issue:
13(8)
Published: Aug. 15, 2022
Abstract
Alzheimer’s
disease
(AD)
is
a
devastating
neurodegenerative
disorder
characterized
by
gradual
loss
of
memory
and
cognitive
function,
which
constitutes
heavy
burden
on
the
healthcare
system
globally.
Current
therapeutics
to
interfere
with
underlying
process
in
AD
still
under
development.
Although
many
efforts
have
centered
toxic
forms
Aβ
effectively
tackle
AD,
considering
unsatisfactory
results
so
far
it
vital
examine
other
targets
therapeutic
approaches
as
well.
The
endoplasmic
reticulum
(ER)
stress
refers
build-up
unfolded
or
misfolded
proteins
within
ER,
thus,
perturbing
ER
cellular
homeostasis.
Emerging
evidence
indicates
that
contributes
onset
development
AD.
A
thorough
elucidation
machinery
pathology
may
help
open
up
new
avenues
management
this
condition
relieve
dementia
symptoms.
Herein,
we
aim
at
deciphering
unique
role
pathogenesis,
reviewing
key
findings,
existing
controversy
an
attempt
summarize
plausible
interventions
pathophysiology.
Brain,
Journal Year:
2023,
Volume and Issue:
146(10), P. 3969 - 3990
Published: May 15, 2023
Results
from
recent
clinical
trials
of
antibodies
that
target
amyloid-β
(Aβ)
for
Alzheimer's
disease
have
created
excitement
and
been
heralded
as
corroboration
the
amyloid
cascade
hypothesis.
However,
while
Aβ
may
contribute
to
disease,
genetic,
clinical,
imaging
biochemical
data
suggest
a
more
complex
aetiology.
Here
we
review
history
weaknesses
hypothesis
in
view
new
evidence
obtained
anti-amyloid
antibodies.
These
indicate
treatments
either
no
or
uncertain
effect
on
cognition.
Despite
importance
definition
argue
point
playing
minor
aetiological
role.
We
also
discuss
suggesting
concerted
activity
many
pathogenic
factors
propose
evolving
multi-factor
models
will
better
underpin
search
effective
strategies
treat
disease.